US 12,227,792 B2
MDA using bead oligonucleotide
Ronald Lebofsky, Kensington, CA (US); Jeremy Agresti, Richmond, CA (US); and George Karlin-Neumann, Palo Alto, CA (US)
Assigned to Bio-Rad Laboratories, Inc., Hercules, CA (US)
Filed by Bio-Rad Laboratories, Inc., Hercules, CA (US)
Filed on Oct. 18, 2023, as Appl. No. 18/381,371.
Application 18/381,371 is a division of application No. 17/508,674, filed on Oct. 22, 2021, granted, now 11,905,551.
Application 17/508,674 is a continuation of application No. 16/012,610, filed on Jun. 19, 2018, granted, now 11,186,862, issued on Nov. 30, 2021.
Claims priority of provisional application 62/522,226, filed on Jun. 20, 2017.
Prior Publication US 2024/0093268 A1, Mar. 21, 2024
Int. Cl. C12Q 1/6806 (2018.01); C12Q 1/6811 (2018.01); C12Q 1/682 (2018.01); C12Q 1/6832 (2018.01); C12Q 1/6853 (2018.01); C12Q 1/686 (2018.01)
CPC C12Q 1/6806 (2013.01) [C12Q 1/6811 (2013.01); C12Q 1/682 (2013.01); C12Q 1/6832 (2013.01); C12Q 1/6853 (2013.01); C12Q 1/686 (2013.01)] 14 Claims
OG exemplary drawing
 
1. A plurality of oligonucleotides of different sequence, the oligonucleotides of different sequence covalently linked to separate solid support beads, the oligonucleotides comprising a 3′ random sequence of at least four contiguous nucleotides, a barcode sequence, and one or more nucleotide sequences, the oligonucleotides annealed to a complementary nucleic acid that is complementary to some or all of the nucleotide sequence, wherein the complementary nucleic acid is not complementary to the barcode sequence or the 3′ random sequence, leaving the 3′ random sequence to be single-stranded, wherein the nucleotide sequence is:
(i) 5′ to the barcode sequence, or
(ii) a sequence that divides the barcode into two or more barcode portions, wherein the barcode portions are separated by the nucleotide sequence.